Forbes

What’s Next For DexCom Stock After A 17% Fall In A Month?

LONDON, ENGLAND - JUNE 17: Dexcom Warriors Roxy Horner, Adam Smith and Henry Slade host Puppy Yoga to promote mental wellbeing for Diabetes Awareness Week on June 17, 2023 in London, England. (Photo ...
CNET

The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM Wearable

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users. Taylor Leamey wrote about all things wellness for CNET, specializing in ...
Forbes

Will DexCom Stock Recover To Its Pre-Inflation Shock Highs Of $160?

Ed Gamble and Roxy Horner, who live with Type 1 diabetes, at the Dexcom's "No Pricks Parlour" vintage ice cream truck, handing out free ice cream on London's South Bank to celebrate Diabetes Awareness ...
San Diego Union-Tribune

EU approves system that includes DexCom monitor

European Union regulators have cleared for sale an insulin pump for diabetics made by Johnson & Johnson that works off a continuous glucose monitor made by DexCom of San Diego, Johnson & Johnson said ...
Healthline

A Review of the Dexcom G6 vs. Abbott FreeStyle Libre: How Do These CGMs Compare?

The Dexcom G6 and Abbott FreeStyle Libre are two of the top continuous glucose monitors (CGMs). Each glucose monitor offers different features and has its own pros and cons. Share on Pinterest ...
The Motley Fool

Why DexCom Stock Is Crashing Today

DexCom beat expectations in the third quarter, and it raised its revenue guidance for the full year. Manufacturing issues are putting pressure on margins. For 2026, the company sees growth missing ...
The Motley Fool

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

DexCom's returns over the past decade have been solid, but not quite on par with the market's. The company has encountered some headwinds in recent years that have sunk its stock price. Despite the ...
Seeking Alpha

Still Too Pricey? DexCom's Double-Digit Growth May Not Be Enough

Dexcom has rebounded since my last update, but I maintain a 'Hold' rating due to continued overvaluation and limited upside potential. Growth remains solid, especially in sensors and U.S. expansion, ...
Benzinga.com

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...

Morgan Stanley upgrades DexCom (DXCM), cites undervalued recovery and G7 margin potential

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...
AZ Central

First of several state-run indoor mass vaccination sites opens in Mesa

An indoor drive-thru mass vaccination facility opened Monday morning in Mesa, intended to serve the East Valley as approaching summer heat forces COVID-19 vaccination efforts inside. The COVID-19 ...